Condition
Idiopathic Short Stature clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Idiopathic Short Stature clinical trials that are recruiting, at sites in 9 countries (most in South Korea (4), United States (3), France (3)). 1 was first registered in the last 30 days. By phase: Phase 3 (2), Phase 2 (1). The most active sponsors are BioMarin Pharmaceutical (2), Xiamen Amoytop Biotech Co., Ltd. (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1New in 30 days
- 9Countries
Newest Idiopathic Short Stature clinical trials
All recruiting trials (8)
-
Long-term Inpegsomatropin Treatment for Idiopathic Short Stature: Extension of Phase III Study
This extension study tests whether continuing Inpegsomatropin injections helps kids with Idiopathic Short Stature who finished a prior phase 3 trial.
-
Once-weekly lonapegsomatropin versus daily somatropin for children and adolescents with short stature due to growth-hormone-sufficient conditions
It will test whether a once-weekly injection of lonapegsomatropin helps children and teens with Turner syndrome, SHOX mutation, small-for-gestational-age, or idiopathic short stature grow as well as or better than daily somatropin.
-
Once-weekly inpegsomatropin versus daily recombinant growth hormone for children with idiopathic short stature
This trial will test whether a once-weekly inpegsomatropin injection works as well and is as safe as daily recombinant human growth hormone in prepubertal children with idiopathic short stature.
-
Evaluating Vosoritide for Children with Short Stature
This study is testing a new treatment called vosoritide to see if it helps children with short stature grow better than the standard growth hormone treatment.
-
Assessing Growth in Children with Short Stature
This study is trying to gather information on how children with unexplained short stature grow to help improve future treatments for them.
-
Multidisciplinary evaluation and whole-genome testing for children with unexplained short stature
We will try whole-genome sequencing plus a team-based clinical review to find genetic causes of unexplained short stature in children aged 4–18.
-
Evaluating the long-term safety and effectiveness of Growtropin®-II in children with short stature
This study is testing whether the Growtropin®-II treatment is safe and effective for children with short stature caused by various conditions, to see how it helps them grow and stay healthy over time.
-
Evaluating long-term safety and effectiveness of growth hormone in children with various conditions
This study is testing how safe and effective growth hormone treatment is for children with conditions like Growth Hormone Deficiency and Turner Syndrome over the long term.
Related topics
Quick answers
How many Idiopathic Short Stature clinical trials are recruiting right now?
8, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in South Korea (4 trials), United States (3 trials), France (3 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.